| Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming A Merino, B Zhang, P Dougherty, X Luo, J Wang, BR Blazar, JS Miller, ... The Journal of clinical investigation 129 (9), 3770-3785, 2019 | 138 | 2019 |
| Impact of a Functional KIR2DS4 Allele on Heterosexual HIV-1 Transmission among Discordant Zambian Couples A Merino, R Malhotra, M Morton, J Mulenga, S Allen, E Hunter, J Tang, ... Journal of infectious diseases 203 (4), 487-495, 2011 | 65 | 2011 |
| Dimorphic HLA-B signal peptides differentially influence HLA-E-and natural killer cell-mediated cytolysis of HIV-1-infected target cells AM Merino, S Sabbaj, J Easlick, P Goepfert, RA Kaslow, J Tang Clinical & Experimental Immunology 174 (3), 414-423, 2013 | 41 | 2013 |
| Unraveling exhaustion in adaptive and conventional NK cells AM Merino, H Kim, JS Miller, F Cichocki Journal of Leucocyte Biology 108 (4), 1361-1368, 2020 | 38 | 2020 |
| KIR2DS4 promotes HIV-1 pathogenesis: new evidence from analyses of immunogenetic data and natural killer cell function AM Merino, AS Dugast, CM Wilson, PA Goepfert, G Alter, RA Kaslow, ... PLoS one 9 (6), e99353, 2014 | 36 | 2014 |
| HLA-B signal peptide polymorphism influences the rate of HIV-1 acquisition but not viral load AM Merino, W Song, D He, J Mulenga, S Allen, E Hunter, J Tang, ... The Journal of infectious diseases 205 (12), 1797-1805, 2012 | 34 | 2012 |
| Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma F Cichocki, R Bjordahl, JP Goodridge, S Mahmood, S Gaidarova, ... Nature communications 13 (1), 7341, 2022 | 25 | 2022 |
| A randomized controlled trial of a CPR decision support video for patients admitted to the general medicine service AM Merino, R Greiner, K Hartwig Journal of hospital medicine 12 (9), 700-704, 2017 | 18 | 2017 |
| Advances in NK cell therapy for hematologic malignancies: NK source, persistence and tumor targeting. A Merino, J Maakaron, V Bachanova Blood Reviews, 101073, 2023 | 16 | 2023 |
| Early adaptive natural killer cell expansion is associated with decreased relapse after autologous transplantation for multiple myeloma AM Merino, RS Mehta, X Luo, H Kim, T De For, M Janakiram, S Cooley, ... Transplantation and cellular therapy 27 (4), 310. e1-310. e6, 2021 | 14 | 2021 |
| Structure of tumor necrosis factor-alpha haploblocks in European populations AM Merino, K Zhang, RA Kaslow, B Aissani Immunogenetics 65, 543-552, 2013 | 10 | 2013 |
| 755P B7H3-targeted tri-specific killer engagers deliver IL-15 to NK cells but not T-cells, and specifically target solid tumors as a pan-tumor antigen strategy mediated through … JS Miller, N Zorko, A Merino, G Phung, M Khaw, P Howard, H Hamsher, ... Annals of Oncology 33, S889, 2022 | 5 | 2022 |
| Adaptive NK cells are expanded by NKG2C-agonist antibodies and retain their cytotoxic and secretory properties A Merino, P Dougherty, B Zhang, JP Houchins, JS Miller, F Cichocki Blood 132, 3695, 2018 | 4 | 2018 |
| B7-H3 Trike Enhances Killing of Myeloid Derived Suppressor Cells in Multiple Myeloma A Merino, H Hamsher, D Mansour, GI Berk, M Felices, MD Miller, S Jeffrey Blood 140 (Supplement 1), 8851-8852, 2022 | 3 | 2022 |
| 126P Novel B7-H3 targeting dual nanobody NK cell engagers display robust activity against a broad spectrum of solid and hematologic malignancies N Zorko, M Felices, A Merino, J Walker, B Kodal, A Lenvik, ZB Davis, ... Annals of Oncology 32, S1433, 2021 | 3 | 2021 |
| Diffuse large B cell lymphoma presenting as transverse myelitis A Merino Minnesota medicine 98 (7), 46, 2015 | 2 | 2015 |
| Impact of melphalan day-1 vs day-2 on outcomes after autologous stem cell transplant for multiple myeloma A Merino, R Shanley, F Rashid, J Langer, M Dolan, S Tu, NE Jurdi, ... Frontiers in Immunology 15, 1310752, 2024 | | 2024 |
| Impact of melphalan day-1 vs day-2 on outcomes after autologous stem cell transplant for multiple myeloma A Merino, R Shanley, F Rashid, J Langer, M Dolan, S Tu, N El Jurdi, ... Frontiers in immunology 15, 2024 | | 2024 |
| An ADAM17-Binding Antibody (MEDI-1) Enhances Proliferation of NK Cells from Multiple Myeloma Patients and Improves Killing with a B7-H3 Tri-Specific Killer Engager (TriKE). A Merino, A Matson, H Hamsher, M Felices, V Bachanova, B Walcheck, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| A tri-specific killer engager (triKE (R)) against b7-h3 (gtb-5550) enhances nk cell mediated killing of multiple myeloma A Merino, H Hamsher, N Zorko, G Berk, M Felices, J Miller BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 332-333, 2022 | | 2022 |
